pd 98059 has been researched along with tigapotide in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Annabi, B; BĂ©liveau, R; Bouzeghrane, M; Currie, JC; Daigneault, L; Dulude, H; Garde, S; Panchal, C; Rabbani, SA; Wu, JJ | 1 |
1 other study(ies) available for pd 98059 and tigapotide
Article | Year |
---|---|
Inhibition of MMP-9 secretion by the anti-metastatic PSP94-derived peptide PCK3145 requires cell surface laminin receptor signaling.
Topics: Antigens, Surface; Bone Neoplasms; Cell Line, Tumor; ELAV Proteins; ELAV-Like Protein 1; Flavonoids; Humans; Laminin; Male; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Oligopeptides; Peptide Fragments; Prostatic Neoplasms; Prostatic Secretory Proteins; Protein Binding; Protein Serine-Threonine Kinases; Receptors, Laminin; RNA-Binding Proteins; Signal Transduction | 2006 |